BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32538752)

  • 1. Expression and prognosis of CyclinA and CDK2 in patients with advanced cervical cancer after chemotherapy.
    Gao Y; Wang H; Zhong A; Yu T
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):85-91. PubMed ID: 32538752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and Significance of LncRNA-MINCR and CDK2 mRNA in Primary Hepatocellular Carcinoma.
    Lian J; Zhang X; Lu Y; Hao S; Zhang Z; Yang Y
    Comb Chem High Throughput Screen; 2019; 22(3):201-206. PubMed ID: 30947664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of immune cell markers and tumor markers in patients with cervical cancer.
    Zhang L; Zhang H; Huang Y; Xi X; Sun Y
    Int J Gynecol Cancer; 2020 Jul; 30(7):969-974. PubMed ID: 32518078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of elevated pretreatment carcinoembryonic antigen in patients with advanced squamous cell carcinoma of the uterine cervix.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Yang SN; Lin FJ
    Tumour Biol; 2008; 29(4):255-61. PubMed ID: 18781097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy.
    Wu MF; Guan MM; Liu CH; Wu JY; Rao QX; Li J
    Cancer Med; 2019 Sep; 8(11):5068-5078. PubMed ID: 31310455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
    Verlooy H; Devos P; Janssens J; Mortelmans L; Gerits M; Bonte J; De Roo M
    Gynecol Obstet Invest; 1991; 32(1):55-8. PubMed ID: 1765320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
    Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
    Chmura A; Wojcieszek A; Mrochem J; Walaszek-Gruszka A; Deja R; Masłyk B; Bartnik W; Sodowski K
    Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor makrers in cervical cancer].
    Markowska J
    Ginekol Pol; 2007 Sep; 78(9):715-8. PubMed ID: 18159826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Kang S; Cho KH
    Int J Gynecol Cancer; 2007; 17(4):872-8. PubMed ID: 17343571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease.
    Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Bidzinski M; Kowalska M
    Tumour Biol; 2016 Jan; 37(1):1271-8. PubMed ID: 26289850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.
    Yang H; Hu H; Gou Y; Hu Y; Li H; Zhao H; Wang B; Li P; Zhang Z
    Int J Clin Oncol; 2018 Apr; 23(2):321-328. PubMed ID: 29101499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer.
    Zhao W; Yu H; Han Z; Gao N; Xue J; Wang Y
    Int J Clin Exp Pathol; 2015; 8(8):9506-11. PubMed ID: 26464712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
    Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
    Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acylglycerol kinase is over-expressed in early-stage cervical squamous cell cancer and predicts poor prognosis.
    Sun F; Xiong Y; Zhou XH; Li Q; Xiao L; Long P; Li LJ; Cai MY; Wei YX; Ma YL; Yu YH
    Tumour Biol; 2016 May; 37(5):6729-36. PubMed ID: 26662108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
    Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
    World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
    Markovina S; Wang S; Henke LE; Luke CJ; Pak SC; DeWees T; Pfeifer JD; Schwarz JK; Liu W; Chen S; Mutch D; Wang X; Powell MA; Siegel BA; Dehdashti F; Silverman GA; Grigsby PW
    Br J Cancer; 2018 Jan; 118(1):72-78. PubMed ID: 29112685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
    Sidorkiewicz I; Zbucka-Krętowska M; Zaręba K; Lubowicka E; Zajkowska M; Szmitkowski M; Gacuta E; Ławicki S
    BMC Cancer; 2019 Apr; 19(1):398. PubMed ID: 31035945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma.
    Hashimoto K; Yonemori K; Katsumata N; Hirakawa A; Hirata T; Yamamoto H; Shimizu C; Tamura K; Ando M; Fujiwara Y
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):394-8. PubMed ID: 21831511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.